More on NRIX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (9.5 Score)
- Holders

Upcoming Events

- Earnings (10/9/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Nurix Therapeutics (NQ:NRIX)
Delayed: 23.38 --0 (-0%)
Prev. Close $23.38  
Open$23.38 
52 Wk High$ 
52 Wk Low$ 
Day High$23.38 
Day Low$23.38 
P/E N/A  
EPS$ 
Volume15,980 

Friends, Peers and Foes (?): S1GE34, CRBU, GTBP, LYEL, SLS (more...)

Jul 22, 2026 07:16 AM Nurix (NRIX) PT Raised to $31 at UBS
Jul 21, 2026 04:01 PM Nurix closes Roche collaboration deal for BTK degrader drug
Jul 21, 2026 04:01 PM Nurix Therapeutics Announces HSR Clearance of Global Collaboration with Roche to Co-Develop and Co-Commercialize Potential Best-in-Class BTK Degrader Bexobrutideg Across Malignant Hematology, Immunolo
Jul 13, 2026 06:43 AM Nurix (NRIX) PT Raised to $34 at Mizuho
Jul 10, 2026 12:48 PM Nurix (NRIX) PT Raised to $34 at Mizuho
Jul 10, 2026 12:08 PM Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'
Jul 10, 2026 07:38 AM Nurix (NRIX) PT Raised to $40 at Stifel
Jul 10, 2026 07:30 AM Nurix (NRIX) PT Raised to $33 at RBC Capital; 'I&I Opportunities Remain Underappreciated'
Jul 10, 2026 07:04 AM Nurix (NRIX) PT Raised at Truist Securities; 'Roche Partnership Broadens Path to Value Creation'
Jul 10, 2026 06:50 AM Nurix (NRIX) PT Raised to $34 at H.C. Wainwright
View All Articles

Entities mentioned with NRIX

View All Entities